ArticlePharmaceutical research2026

Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists.

Katharina L Kopp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.